PENUMBRA INC (PEN)

US70975L1070 - Common Stock

240.49  +1.29 (+0.54%)

After market: 240.49 0 (0%)

News Image
a day ago - Penumbra, Inc.

Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference

/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Piper Sandler 36th Annual Healthcare...

News Image
a month ago - The Motley Fool

Why Penumbra Stock Zoomed 4% Higher Today

The latest news from the lab, plus an analyst's bullish move, combined to put some zip in the company's shares.

News Image
2 months ago - Penumbra, Inc.

Penumbra, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for October 30, 2024

/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the third quarter 2024 after...

News Image
2 months ago - The Motley Fool

Why Penumbra Stock Zoomed Nearly 5% Higher Today

The company might just be the right kind of business operating at the right time in history.

News Image
2 months ago - Penumbra, Inc.

Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash™ 2.0 and Lightning Bolt™ 7 - in Europe

Latest computer assisted vacuum thrombectomy (CAVT) technologies combine superior catheter design with the latest dual clot detection computer algorithms...

News Image
3 months ago - Penumbra, Inc.

Penumbra, Inc. to Present at the Baird Global Healthcare Conference

/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Baird Global Healthcare Conference on...

News Image
3 months ago - Penumbra, Inc.

Penumbra, Inc. to Present at the Wells Fargo Healthcare Conference

/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Wells Fargo Healthcare Conference on...

News Image
3 months ago - Penumbra, Inc.

Penumbra, Inc. Announces $200 Million Share Repurchase Authorization

/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today announced that its Board of Directors approved on August 5, 2024 a...

News Image
4 months ago - Penumbra, Inc.

Penumbra, Inc. to Present at the Canaccord Genuity Growth Conference

/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Canaccord Genuity Growth Conference on...

News Image
4 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

It's time to dive into the biggest pre-market stock movers for Wednesday as we check out all of the hottest news happening this morning!

News Image
4 months ago - BusinessInsider

PEN Stock Earnings: Penumbra Beats EPS, Beats Revenue for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Penumbra (NYSE:PEN) just reported results for the second quarter of 2024.Penumb...

News Image
4 months ago - InvestorPlace

PEN Stock Earnings: Penumbra Beats EPS, Beats Revenue for Q2 2024

PEN stock results show that Penumbra beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

News Image
4 months ago - Penumbra, Inc.

Penumbra, Inc. Reports Second Quarter 2024 Financial Results

/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the second...

News Image
4 months ago - Market News Video

First Week of PEN September 20th Options Trading

News Image
5 months ago - Penumbra, Inc.

Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024

/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the second quarter 2024 after...

News Image
5 months ago - Market News Video

Penumbra Becomes Oversold (PEN)